Introduction Colorectal cancer is a leading cause of cancer-related death worldwide.
Metastatic liver disease develops in 50% of cases and drives patient outcomes. Although the …

The novel coronavirus disease 2019 (COVID-19) pandemic has posed an unprecedented
challenge to healthcare systems worldwide, causing downscaling of almost all other …

Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has
been improving, but at a slower rate than other cancers. Multimodal treatment, including …

Background Operable stage I-III non-small cell lung cancer (NSCLC) has a high risk of
recurrence, mainly due to remnant clones of the disease defined as minimal residual …

The rising utilization of circulating tumor DNA (ctDNA) assays in Precision Oncology may
incidentally detect genetic material from secondary sources. It is important that such findings …

The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a
significant paradigm shift in recent years with the rising adoption of total neoadjuvant …

Abstract Purpose of Review Leptomeningeal disease (LMD) is a devastating complication of
advanced metastatic cancer associated with a poor prognosis and limited treatment options …

In solid tumor oncology, circulating tumor DNA (ctDNA) is poised to transform care through
accurate assessment of minimal residual disease (MRD) and therapeutic response …

The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring
highquality patient care by advancing the science, prevention, and management of …

Anatomic surgical resection followed by cisplatin-based platinum-doublet adjuvant
chemotherapy has been a long-standing standard of care for patients with early-stage …